{
    "title": "Nasal spray alternative to EpiPen faces setback as FDA seeks fresh study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12540669/Nasal-spray-alternative-EpiPen-faces-setback-FDA-seeks-fresh-study.html",
    "date": "2023-09-20",
    "keywords": [
        "fda",
        "spray",
        "treatment",
        "decision",
        "anaphylaxis",
        "roy",
        "jahnavi",
        "nidumolu",
        "health",
        "food",
        "drug",
        "neffy",
        "standard",
        "application",
        "time",
        "half",
        "regulator",
        "nasal",
        "emergency",
        "surprise",
        "developer",
        "record",
        "rejection",
        "request",
        "testing",
        "backing",
        "administration",
        "pharma",
        "tuesday",
        "repeatdose",
        "study",
        "product",
        "approval",
        "august",
        "company",
        "blair",
        "analyst",
        "tim",
        "lugo",
        "epipenmaker",
        "viatris",
        "june",
        "realworld",
        "alternative",
        "epinephrine",
        "risk",
        "rhinitis",
        "attack",
        "response",
        "reaction",
        "lack",
        "allergist",
        "texas",
        "tech",
        "university",
        "anything",
        "trust",
        "lianne",
        "mandelbaum",
        "parent",
        "child",
        "auto",
        "care",
        "choice",
        "trading",
        "reporting",
        "santhosh",
        "sriparna",
        "bengaluru",
        "editing",
        "kalluvila",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}